Chao J, Margolius H S
Biochim Biophys Acta. 1979 Oct 11;570(2):330-40. doi: 10.1016/0005-2744(79)90153-0.
Suspensions of viable renal cortical cells hydrolyzed a synthetic ester substrate (alpha-N-tosyl-L-arginine methyl ester, Tos-Arg-OMe) and generated kinins from a kininogen substrate. This kallikrein-like esterase activity increased linearly with cell number, or time of exposure to substrate. No radiolabelled substrate or product was found within the cells. Most of the activity appeared to be on cell surfaces as supernatant media had less than 20% of the Tos-Arg-OMe esterase activity on the cell suspensions. Cell surface Tos-Arg-OMe esterase activity was inhibited by aprotinin, benzamidine, pentamidine, and a tris-amidine derivative (alpha,alpha',alpha''-tris(3-amidinophenoxy)mesitylene). Preincubation of cells with phospholipase A2 increased renal cell surface esterase activity up to 76% while only slightly increasing supernatant activity. In contrast, preincubation with deoxycholate caused clearing of suspensions and a marked increase in supernatant esterase activity. Renal cell kininogenase (EC 3.4.21.8) activity was inhibited by preincubation with aprotinin, the tris-amidine derivative, or anti-rat urinary kallikrein antibody. Kallikrein elaborated by renal cells formed a single precipitin line with an antibody to rat urinary kallikrein but the two enzymes were not immunologically identical. We conclude that kallikrein's active sites are facing the external environment of renal cortical cells in suspension with access to substrates, inhibitors, and antibody.
存活的肾皮质细胞悬液可水解一种合成酯底物(α-N-对甲苯磺酰-L-精氨酸甲酯,Tos-Arg-OMe),并从激肽原底物生成激肽。这种类激肽释放酶酯酶活性随细胞数量或与底物接触的时间呈线性增加。在细胞内未发现放射性标记的底物或产物。大部分活性似乎存在于细胞表面,因为上清培养基中Tos-Arg-OMe酯酶活性不到细胞悬液的20%。细胞表面Tos-Arg-OMe酯酶活性受到抑肽酶、苯甲脒、喷他脒和一种三脒衍生物(α,α',α''-三(3-脒基苯氧基)均三甲苯)的抑制。用磷脂酶A2预孵育细胞可使肾细胞表面酯酶活性提高达76%,而上清活性仅略有增加。相反,用脱氧胆酸盐预孵育会导致悬液澄清,上清酯酶活性显著增加。肾细胞激肽原酶(EC 3.4.21.8)活性在与抑肽酶、三脒衍生物或抗大鼠尿激肽释放酶抗体预孵育后受到抑制。肾细胞产生的激肽释放酶与抗大鼠尿激肽释放酶抗体形成单一沉淀线,但这两种酶在免疫上并不相同。我们得出结论,激肽释放酶的活性位点面向悬浮肾皮质细胞的外部环境,可接触底物、抑制剂和抗体。